Huang, L. #, Y. Wang#, J. Chen#, Y. Wang, Y. Zhao, Y. Wang, Y. Ma, X. Chen, W. Liu, Z. Li, L. Zhao, B. Shan, X. Dong, D. Li, S. Shao, Y. Song, Q. Zhan*and X. Liu* Long noncoding RNA PCAT1, a novel serum-based biomarker, enhances cell growth by sponging miR-326 in oesophageal squamous cell carcinoma.,Cell Death Dis,10(7): 513.

Teng H#, Wang Y#, Sui X#, et al. Gut microbiota-mediated nucleotide synthesis attenuates the response to neoadjuvant chemoradiotherapy in rectal cancer.,Cancer Cell,41(1):124-138.e6.

Xiaohan Gao#, Yan Wang#, Fang Lu, Xu Chen, Weimin Zhang, Jie Chen, Leilei Zheng, Di Yang, Weimin Zhang, Jie Chen, Leilei Zheng, Guangchao Wang, Ming Fu, Liying Ma, Yongmei Song, and Qimin Zhan*. Extracellular vesicles derived from esophageal cancer containing P4HB promote muscle wasting via regulating PHGDH/Bcl-2/caspase-3 pathway,Journal of Extracellular Vesicles,10:e12060

Chen J#, Wang Y#, et al. Membranous NOX5-derived ROS oxidizes and activates local Src to promote malignancy of tumor cells.,Signal Transduct Target Ther,5:139.

Min Q#, Wang Y#, Wu Q#, et al. Genomic and epigenomic evolution of acquired resistance to combination therapy in esophageal squamous cell carcinoma.,JCI Insight,2021;6.

Wang, Y. #, Y. Wang#, J. Liang, W. Cai, Z. Sun, Y. Wang and H. Teng* Androgen deprivation drives variation of androgen receptor trinucleotide repeats.,Acta Biochim Biophys Sin (Shanghai),51(9): 972-975.

肿瘤癌恶病质的微环境调控机制和转化研究

P4HB抑制剂在治疗或预防肿瘤恶病质中的用途，获批年份2022， 詹启敏，王嫣，高晓寒。, 发明专利, 第2完成人, 国家专利局, 中国, 2022.3

silncRNA16、纳米靶向药物及其治疗铂类耐药肿瘤中的用途, 发明专利, 第4完成人, 国家知识产权局, 中国, 2023.6

胞外囊泡蛋白P4HB通过调控UCP1促进食管鳞癌恶病质脂肪棕色化的作用和机制研究, 课题负责人, 2022.1.1～2025.12.31, 国自然面上项目

中国高发肿瘤单细胞多组学整合分析及转化研究, 子课题负责人, 2022.10.1～2027.9.30, 国家重点研发项目

Gadd45α调控脂代谢的分子机制研究, 课题负责人, 2018.1.1～2020.12.31, 国自然青年基金

食管癌基因组学大数据, 课题负责人, 2019.1.1～2019.12.31, 高精尖学科建设项目